PDL Biopharma
PDLI
#8048
Rank
HK$2.19 B
Marketcap
HK$19.21
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Revenue for PDL Biopharma (PDLI)

Revenue in 2020 (TTM): HK$0.62 Billion

According to PDL Biopharma 's latest financial reports the company's current revenue is HK$0.62 Billion. In 2018 the company made a revenue of HK$1.52 Billion a decrease over the revenue in the year 2017 that were of HK$2.35 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PDL Biopharma from 2001 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)HK$0.62 B
2018HK$1.52 B-35.24%
2017HK$2.35 B41.34%
2016HK$1.66 B-61.41%
2015HK$4.31 B1.67%
2014HK$4.23 B23.08%
2013HK$3.44 B18.26%
2012HK$2.91 B3.45%
2011HK$2.81 B4.95%
2010HK$2.68 B8.42%
2009HK$2.47 B8.13%
2008HK$2.28 B
2006HK$3.21 B48.05%
2005HK$2.17 B191.23%
2004HK$0.74 B32.84%
2003HK$0.56 B53.73%
2002HK$0.36 B5.97%
2001HK$0.34 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Compugen
CGEN
HK$53.68 M-91.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$279.73 B 44,519.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$0.48 B-22.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$462.09 B 73,605.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.25 B-59.22%๐Ÿ‡บ๐Ÿ‡ธ USA